MedPath

Whole Body Vibration Training on Body Composition

Not Applicable
Withdrawn
Conditions
Physical Fitness
Body Composition, Beneficial
Interventions
Device: HyperVibe Whole Body Vibration training device
Other: Aerobic Exercise
Registration Number
NCT02571322
Lead Sponsor
University of Miami
Brief Summary

The purpose of the study is to determine the effect of whole-body vibration (WBV) on body composition, physical fitness, and quality of life.

Detailed Description

The purpose of the study is to determine the effect of whole-body vibration (WBV) on body composition, physical fitness, and quality of life.Twenty healthy adult males and females (ages 18-65) with no contraindications for exercise training will be recruited to participate in the study. Subjects will participate in a randomized, crossover trial for 24 weeks. Subjects will be assigned to either: (1) WBV for the first 12 weeks and then aerobic exercise training for the second 12 weeks 3 times per week (n=10) or (2) aerobic exercise training for the first 12 weeks and then WBV for the second 12 weeks 3 times per week (n=10). Subjects will be assessed at baseline and at 12 and 24 weeks on aerobic capacity (estimated VO2max), upper and lower body strength (1-repetition maximum on bench press and leg press, respectively), compartmental and total body fat mass, fat free mass, and bone mineral density (using dual energy x-ray absorptiometry (DEXA)), body mass index (height relative to weight), weight, skin fold and body part circumferences, resting blood pressure and pulse, and subjective health-related quality of life (SF-36). Participants will be trained and assessed at the University of Miami Miller School of Medicine UHealth Fitness and Wellness Center, in UHealth Champions Executive Medicine, and in the Department of Psychiatry and Behavioral Sciences.

No substantial psychological, medical, or social risks exist to the participants. Although all measures to protect confidentiality will be put in place, the possibility exists that electronic data could be jeopardized. In the remote case that such event occurs, it will be immediately reported to the Institutional Review Board (IRB).

Exercise has been shown to be safe among every population, including those with chronic diseases and/or other complications. A DEXA scan is the equivalent of about 4 extra days' worth of naturally-occurring radiation.

The use of the HyperVibe WBV training device should be harmless without any known negative effects, as WBV is even lower risk than aerobic exercise, as the participant simply stands on the platform without moving while being exposed to full-body vibration. The system is completely non-invasive, and no serious, untoward side effects have been reported to the manufacturer (HyperVibe) of this system. All study personnel will follow instructions for operating the system. Participants will incur no additional appreciable psychological or social risks by participating in this study.

The results obtained in this study may demonstrate a way to increase exercise efficiency through the use of WBV in helping overweight/obese participants to lose weight, gain muscular weight, and improve physical fitness levels. By participating in the study, subjects may improve their overall health status in a unique approach to exercise training. The minimal risk of participating in this study is reasonable because the potential information gained can be worthwhile for helping people to lose weight, which is significant, given the inordinate prevalence of overweight/obesity and its co morbid chronic diseases in the United States today.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  1. Men and women ages 18 to 65 years old
  2. Interest in participating in a study to investigate the effects of a novel exercise training style
  3. Willing to follow recommendations for participating in the study
  4. Able to provide informed consent to participate in the study
Read More
Exclusion Criteria
  1. Women who are pregnant or attempting pregnancy during the next 24 weeks
  2. Anyone with a cardiovascular, orthopedic, or other physical condition that would be contraindicated for an exercise training program
  3. Any condition where WBV is contraindicated, e.g., seizure disorder
  4. Currently enrolled in another exercise intervention research study
  5. Currently undergoing internal defibrillation, like with an implantable heart device
  6. Erratic, accelerated, or mechanically controlled irregular heart rhythms
  7. Atrial fibrillation/flutter
  8. Atrioventricular block
  9. Recently had dyes introduced into the bloodstream, such as methylene blue, indocyanine green, indigo carmine, and fluorescein
  10. Any implanted electronic device
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Whole Body Vibration trainingHyperVibe Whole Body Vibration training deviceUse of the HyperVibe Whole Body Vibration training device for 12 weeks 3 times per week crossover to aerobic exercise
Aerobic ExerciseAerobic ExerciseAerobic exercise training for 12 weeks 3 times per week crossover to use of the HyperVibe Whole Body Vibration training device
Primary Outcome Measures
NameTimeMethod
Change from baseline in aerobic capacityBaseline,12 weeks and 24 weeks

Aerobic capacity and strength will be assessed by Graded Exercise Test

Change from baseline in body strengthBaseline,12 weeks and 24 weeks

Overall upper and lower body strength will be assessed by one-repetition maximum strength tests

Change from baseline in bone mineral densityBaseline,12 weeks and 24 weeks

Bone mineral density will be assessed by DEXA scan

Change from baseline in body compositionBaseline,12 weeks and 24 weeks

Body composition will be evaluated by DEXA scan which measure fat free mass , total body and compartmental fat mass

Secondary Outcome Measures
NameTimeMethod
Change from baseline in systolic blood pressureBaseline,12 weeks and 24 weeks

Systolic blood pressure will be measured to the nearest even digit by use of the Microlife Deluxe upper arm blood pressure monitor. Three readings will be made with the subjects seated after they have rested for five minutes. The average of the three readings will be used in the analysis

Change from baseline in physical activityBaseline,12 weeks and 24 weeks

Physical activity will be assessed with International Physical Activity Questionnaire (IPAQ). The IPAQ items are structured to provide individual domain specific scores for walking, moderate-intensity, and vigorous activity within the domains of work, transportation, domestic chores and gardening, and leisure-time. The tool asks about the time spent doing a specific physical activity in the last 7 days. For total scores, the duration (in minutes) and frequency for all types of activities in all domains are summed, while specific domain scores are calculated by the summation of the walking, moderate-intensity and vigorous-intensity activities within the specific domain. For activity-specific scores, the scores for the specific type of activity across domains are added. To measure the volume of activity, each type of activity is weighted by its energy requirement defined as the metabolic equivalent of task-minute (MET-min).

Change from baseline in quality of lifeBaseline,12 weeks and 24 weeks

The SF-36 (v2) Health Survey provides psychometrically-based physical and mental health summary measures and a preference-based health utility index. It is a generic measure that does not target a specific age, disease, or treatment group.

Change from baseline in diastolic blood pressureBaseline,12 weeks and 24 weeks

Diastolic blood pressure will be measured to the nearest even digit by use of the Microlife Deluxe upper arm blood pressure monitor. Three readings will be made with the subjects seated after they have rested for five minutes. The average of the three readings will be used in the analysis

Trial Locations

Locations (1)

University of Miami Miller School of Medicine, Clinical Research Building, Department of Psychiatry & Behavioral Sciences

🇺🇸

Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath